<code id='01E71326B5'></code><style id='01E71326B5'></style>
    • <acronym id='01E71326B5'></acronym>
      <center id='01E71326B5'><center id='01E71326B5'><tfoot id='01E71326B5'></tfoot></center><abbr id='01E71326B5'><dir id='01E71326B5'><tfoot id='01E71326B5'></tfoot><noframes id='01E71326B5'>

    • <optgroup id='01E71326B5'><strike id='01E71326B5'><sup id='01E71326B5'></sup></strike><code id='01E71326B5'></code></optgroup>
        1. <b id='01E71326B5'><label id='01E71326B5'><select id='01E71326B5'><dt id='01E71326B5'><span id='01E71326B5'></span></dt></select></label></b><u id='01E71326B5'></u>
          <i id='01E71326B5'><strike id='01E71326B5'><tt id='01E71326B5'><pre id='01E71326B5'></pre></tt></strike></i>

          Home / comprehensive / fashion

          fashion


          fashion

          author:comprehensive    Page View:643
          David L. Ryan/Boston Globe

          A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines.

          The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

          advertisement

          Backed by deep-pocketed investors including Steve Pagliuca, the former co-chair of Bain Capital and Celtics co-owner, and high-tech mogul Michael Dell, Arena has already lured top scientists from academic labs with lucrative compensation packages, but so far has publicly named only a few.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In